1. Home
  2. AEVA vs INBX Comparison

AEVA vs INBX Comparison

Compare AEVA & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeva Technologies Inc.

AEVA

Aeva Technologies Inc.

HOLD

Current Price

$15.29

Market Cap

1.1B

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$109.91

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEVA
INBX
Founded
2019
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.5B
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
AEVA
INBX
Price
$15.29
$109.91
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$26.50
$150.00
AVG Volume (30 Days)
1.3M
321.8K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
10.53
N/A
EPS
N/A
N/A
Revenue
N/A
$1,300,000.00
Revenue This Year
$85.37
N/A
Revenue Next Year
$132.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
550.00
52 Week Low
$8.83
$28.16
52 Week High
$31.30
$155.29

Technical Indicators

Market Signals
Indicator
AEVA
INBX
Relative Strength Index (RSI) 41.71 57.96
Support Level $14.38 $72.39
Resistance Level $16.84 $131.01
Average True Range (ATR) 0.79 7.56
MACD 0.12 -1.29
Stochastic Oscillator 31.37 62.28

Price Performance

Historical Comparison
AEVA
INBX

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: